Results 251 to 260 of about 11,034,532 (299)
Some of the next articles are maybe not open access.
Endotoxemia in End‐Stage Kidney Disease
Seminars in Dialysis, 2014AbstractChronic unexplained inflammation remains a prevalent and clinically significant problem for patients with end‐stage kidney disease (ESKD), especially in the dialysis population. The causes of persistent inflammation are likely to be multifactorial, but the underlying mechanisms remain to be elucidated.
Jonathan, Wong +2 more
openaire +2 more sources
End‐stage kidney disease in Fiji
Internal Medicine Journal, 2019AbstractBackgroundChronic kidney disease is now a leading cause of death in Fiji. The country lacks even basic statistics about the incidence of end‐stage kidney disease (ESKD) and presents significant challenges to conducting clinical research.AimTo estimate the incidence and characteristics of ESKD in Fijian adults.MethodsA retrospective cohort study
Amrish Krishnan +5 more
openaire +2 more sources
Palliative care in end‐stage kidney disease
Nephrology, 2010ABSTRACTPatients with end‐stage kidney disease have significantly increased morbidity and mortality. While greater attention has been focused on advanced care planning, end‐of‐life decisions, conservative therapy and withdrawal from dialysis these must be supported by adequate palliative care incorporating symptom control.
Fassett, Robert +5 more
openaire +5 more sources
Acquired Cystic Disease of the End-Stage Kidney
Journal of Urology, 1985The development of multiple cysts in the previously noncystic chronically diseased kidneys of patients undergoing long-term dialysis appears to be associated with spontaneous renal bleeding and benign and malignant renal tumors. Two cases of acquired cystic disease with renal hemorrhage and adenocarcinoma are presented; metastases occurred in one ...
J J, Gehrig +2 more
openaire +2 more sources
Cancer Screening in End-Stage Kidney Disease
Advances in Chronic Kidney Disease, 2021The incidence of cancer is higher in patients with end-stage kidney disease (ESKD) than among the general population. Despite this, screening for cancer is generally not cost-effective and may worsen quality of life in these patients. This is due to high mortality rates (patients are not living long enough to reap the benefits of screening), the ...
Shayan Shirazian +2 more
openaire +2 more sources
Clopidogrel Use in End‐Stage Kidney Disease
Seminars in Dialysis, 2014AbstractClopidogrel irreversibly binds to the P2Y12 platelet receptor and acts as a potent inhibitor of platelet activation and aggregation. It is currently recommended for the prevention of cardiovascular events in patients with acute coronary syndromes, recent ischemic stroke, and peripheral arterial disease.
Bassem Y, Tanios +2 more
openaire +2 more sources
Pathology of end-stage kidney disease
The American Journal of Medicine, 1968Abstract The various pathologic pictures which make up the end-stage kidney are described. Certain patterns of involvement persist, even in patients with long continued chronic renal failure, that may permit one to make a diagnosis. In some cases, however, it may not be possible to arrive at an accurate diagnosis; this is particularly true of the ...
openaire +2 more sources
Cardiorenal Syndrome in End-Stage Kidney Disease
Blood Purification, 2015<b><i>Background:</i></b> Cardiorenal syndrome (CRS) in patients with end-stage kidney disease (ESKD) represents mainly cardiovascular disease (CVD) due to various complications associated with renal dysfunction—defined as type 4 CRS by Ronco et al.—because the effect of cardiac dysfunction on the kidneys does not need to be ...
Kazuhiko, Tsuruya +4 more
openaire +2 more sources
Lupus Nephritis and End-stage Kidney Disease
The American Journal of the Medical Sciences, 2013Systemic lupus erythematosus (SLE) is a multisystem disease affecting many organs. Varying degrees of renal involvement are seen in up to 60% of adults with SLE, and severe lupus nephritis (LN) (World Health Organization class III and above) progresses to end-stage kidney disease (ESKD) within 15 years of diagnosis in 10% to 30% of patients.
Natallia, Maroz, Mark S, Segal
openaire +2 more sources
Renal Adenocarcinoma and End Stage Kidney Disease
Journal of Urology, 1987The association of end stage kidney disease with cystic degeneration and renal adenocarcinoma was first recognized in 1977. Since then a number of reports have confirmed this relationship. Duration of dialysis has been the most strongly associated risk factor. We report 8 cases of end stage kidney disease and renal adenocarcinoma.
M, Boileau +3 more
openaire +2 more sources